NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

The MHRA is a UK Government agency. IMO we cannot rule out the influence that Government can perhaps bring to the speed of approving certain drugs, in particluarly drugs for an urgent unmet need, rare orphan designated condition in the UK (gbm is exactly recognised as such)

With regards to having 'swift approval' the UK Health secretary clearly stated the Government's wishes in his spring 2023 budget statement:-

Spring Budget 2023 speech
Spring Budget 2023 speech as delivered by Chancellor Jeremy Hunt.[color=red][/color]

"We are lucky with the MHRA to have one of the most respected drugs regulators in the world, indeed the very first to licence a Covid vaccine.

From 2024, they will move to a different model which will allow rapid, often near automatic sign-off for medicines and technologies already approved by trusted regulators in other parts of the world such as the United States, Europe or Japan.

At the same time from next year they will set up a[color=red] swift new approval process for the most cutting-edge medicines [/color]and devices to ensure the UK becomes a global centre for their development.

And with an extra £10m of funding over the next two years they will put in place the quickest, simplest, regulatory approval in the world for companies seeking rapid market access".


https://www.gov.uk/government/speeches/spring-budget-2023-speech#:~:text=From%202024%2C%20they%20will%20move,United%20States%2C%20Europe%20or%20Japan.